Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–25.
Monnet F, Dupont C, Pivodic L. In global approaches to dementia research, do not forget care. Nat Med. 2023:1-.
Global health estimates. Leading causes of death. 2022.
Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, et al. Antihypertensive medications and risk for incident dementia and Alzheimer’s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol. 2020;19(1):61–70.
Article CAS PubMed Google Scholar
Reitz C. Dyslipidemia and the risk of Alzheimer’s disease. Curr Atheroscler Rep. 2013;15(3):1–9.
Kim D, Yang PS, Yu HT, Kim TH, Jang E, Sung JH, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. Eur Heart J. 2019;40(28):2313–23.
Article CAS PubMed Google Scholar
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46.
Article PubMed PubMed Central Google Scholar
Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64(2):277–81.
Article CAS PubMed Google Scholar
Chang K-H, Chung C-J, Lin C-L, Sung F-C, Wu T-N, Kao C-H. Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis. Age. 2014;36(2):967–75.
Hwangbo S, Lee JY, Han G, Chun MY, Jang H, Seo SW et al. Dementia incidence and population-attributable fraction for dementia risk factors in Republic of Korea: a 12-year longitudinal follow-up study of a national cohort. Front Aging Neurosci. 2023;15.
Zhu X-C, Tan L, Wang H-F, Jiang T, Cao L, Wang C et al. Rate of early onset Alzheimer’s disease: a systematic review and meta-analysis. Annals Translational Med. 2015;3(3).
Panegyres PK, Chen H-Y. Differences between early and late onset Alzheimer’s disease. Am J Neurodegenerative Disease. 2013;2(4):300.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 2011;7(3):270–9.
Spina S, La Joie R, Petersen C, Nolan AL, Cuevas D, Cosme C, et al. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease. Brain. 2021;144(7):2186–98.
Article PubMed PubMed Central Google Scholar
Tolnay M, Clavaguera F. Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. Neuropathology. 2004;24(4):269–83.
Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S, et al. TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol. 2011;122:703–13.
Hughes TF, Ganguli M. Modifiable midlife risk factors for late-life cognitive impairment and dementia. Curr Psychiatry Reviews. 2009;5(2):73–92.
Mukadam N, Anderson R, Knapp M, Wittenberg R, Karagiannidou M, Costafreda SG, et al. Effective interventions for potentially modifiable risk factors for late-onset dementia: a costs and cost-effectiveness modelling study. Lancet Healthy Longev. 2020;1(1):e13–20.
Masellis M, Sherborn K, Neto PR, Sadovnick DA, Hsiung G-YR, Black SE, et al. Early-onset dementias: diagnostic and etiological considerations. Alzheimers Res Ther. 2013;5(1):1–22.
PubMed PubMed Central Google Scholar
Fancourt D, Steptoe A, Cadar D. Community engagement and dementia risk: time-to-event analyses from a national cohort study. J Epidemiol Community Health. 2020;74(1):71–7.
Lee YT, Lee HC, Hu CJ, Huang LK, Chao SP, Lin CP, et al. Periodontitis as a modifiable risk factor for dementia: a nationwide population-based cohort study. J Am Geriatr Soc. 2017;65(2):301–5.
Garre-Olmo J, Batlle DG, del Mar Fernández M, Daniel FM, de Eugenio Huélamo R, Casadevall T, et al. Incidence and subtypes of early-onset dementia in a geographically defined general population. Neurology. 2010;75(14):1249–55.
Article CAS PubMed Google Scholar
Craig MC, Murphy D. Estrogen therapy and Alzheimer’s dementia. Ann N Y Acad Sci. 2010;1205(1):245–53.
McMurtray A, Clark DG, Christine D, Mendez MF. Early-onset dementia: frequency and causes compared to late-onset dementia. Dement Geriatr Cogn Disord. 2006;21(2):59–64.
Ueki A, Shinjo H, Shimode H, Nakajima T, Morita Y. Factors associated with mortality in patients with early-onset Alzheimer’s disease: a five‐year longitudinal study. Int J Geriatr Psychiatry. 2001;16(8):810–5.
Article CAS PubMed Google Scholar
Leibson CL, Rocca WA, Hanson V, Cha R, Kokmen E, O’brien P, et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol. 1997;145(4):301–8.
Article CAS PubMed Google Scholar
Katon W, Pedersen HS, Ribe AR, Fenger-Grøn M, Davydow D, Waldorff FB, et al. Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry. 2015;72(6):612–9.
Article PubMed PubMed Central Google Scholar
Strachan MW, Reynolds RM, Marioni RE, Price JF. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Reviews Endocrinol. 2011;7(2):108–14.
Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N, et al. Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care. 2016;39(2):300–7.
Article CAS PubMed Google Scholar
Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64–74.
Kim B, Feldman EL. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med. 2015;47(3):e149–e.
Article CAS PubMed PubMed Central Google Scholar
Unger JW, Livingston JN, Moss AM. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol. 1991;36(5):343–62.
Article CAS PubMed Google Scholar
Marioni RE, Strachan MW, Reynolds RM, Lowe GD, Mitchell RJ, Fowkes FGR, et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes. 2010;59(3):710–3.
Article CAS PubMed Google Scholar
McEwen BS. Stress and the aging hippocampus. Front Neuroendocr. 1999;20(1):49–70.
Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res. 2009;1280:186–94.
Article CAS PubMed PubMed Central Google Scholar
Fan Y-C, Hsu J-L, Tung H-Y, Chou C-C, Bai C-H. Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study. Alzheimers Res Ther. 2017;9(1):1–10.
Weller I, Schatzker J. Hip fractures and Alzheimer’s disease in elderly institutionalized canadians. Ann Epidemiol. 2004;14(5):319–24.
Haasum Y, Fastbom J, Fratiglioni L, Johnell K. Undertreatment of osteoporosis in persons with dementia? A population-based study. Osteoporos Int. 2012;23:1061–8.
Article CAS PubMed Google Scholar
Jørgensen IF, Aguayo-Orozco A, Lademann M, Brunak S. Age‐stratified longitudinal study of Alzheimer’s and vascular dementia patients. Alzheimer’s Dement. 2020;16(6):908–17.
Lary CW, Rosen CJ, Kiel DP. Osteoporosis and dementia: establishing a link. J bone Mineral Research: Official J Am Soc Bone Mineral Res. 2021;36(11):2103.
de Bruijn RF, Heeringa J, Wolters FJ, Franco OH, Stricker BH, Hofman A, et al. Association between atrial fibrillation and dementia in the general population. JAMA Neurol. 2015;72(11):1288–94.
Rusanen M, Kivipelto M, Levälahti E, Laatikainen T, Tuomilehto J, Soininen H, et al. Heart diseases and long-term risk of dementia and Alzheimer’s disease: a population-based CAIDE study. J Alzheimers Dis. 2014;42(1):183–91.
Nah M-A, Lee KS, Hwang T-Y. Association between atrial fibrillation and the risk of dementia in the Korean elderly: a 10-year nationwide cohort study. J Prev Med Public Health. 2020;53(1):56.
Comments (0)